![]() | This article is rated Start-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
|
![]() | Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about Regorafenib.
|
Good results on phase III for advanced gastrointestinal stromal tumors (GIST) - see New Targeted Treatment May Slow Disease in Patients with Advanced GIST. - Rod57 ( talk) 23:09, 12 December 2012 (UTC)
Cost benefit could be added. - Rod57 ( talk) 10:35, 29 July 2015 (UTC)
![]() | This article is rated Start-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
|
![]() | Ideal sources for Wikipedia's health content are defined in the guideline
Wikipedia:Identifying reliable sources (medicine) and are typically
review articles. Here are links to possibly useful sources of information about Regorafenib.
|
Good results on phase III for advanced gastrointestinal stromal tumors (GIST) - see New Targeted Treatment May Slow Disease in Patients with Advanced GIST. - Rod57 ( talk) 23:09, 12 December 2012 (UTC)
Cost benefit could be added. - Rod57 ( talk) 10:35, 29 July 2015 (UTC)